Our study found metformin-inhibited replication of HCV was associated with IFN signaling activation in hepatoma cells harboring genotype 2a (JFH-1 infected Huh 7.5.1 cells) and genotype 1b (OR-6 cells). This evidence concerns the gene IFNA1 and hepatocellular carcinoma.